Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jan 11, 2023 | Jan 13, 2023 | Mendlein John Dir | Buy | Fate Therapeutics Inc | FATE | $5.6 | $698,138 | +30.60% |
Jun 03, 2022 | Jun 06, 2022 | Mendlein John Dir | Sell | Fate Therapeutics Inc | FATE | $22.79 | $31,086 | -0.86% |
Mar 10, 2022 | Mar 11, 2022 | Mendlein John Dir | Sell | Fate Therapeutics Inc | FATE | $35.02 | $1M | -16.52% |
Dec 20, 2018 | Dec 26, 2018 | Mendlein John Dir | Buy | Atyr Pharma Inc | LIFE | $0.42 | $103,247 | +28.48% |
Aug 31, 2017 | Sep 05, 2017 | Mendlein John CEO Dir | Buy | Atyr Pharma Inc | LIFE | $2.65 | $100,000 | +9.30% |
Apr 24, 2017 | Apr 26, 2017 | Mendlein John CEO Dir | Buy | Atyr Pharma Inc | LIFE | $3 | $372 | +0.04% |
Apr 18, 2017 | Apr 20, 2017 | Mendlein John CEO Dir | Buy | Atyr Pharma Inc | LIFE | $3 | $7,656 | +0.77% |
Dec 19, 2016 | Dec 21, 2016 | Mendlein John CEO Dir | Buy | Atyr Pharma Inc | LIFE | $2.2 | $151,662 | +17.51% |
Apr 05, 2016 | Apr 07, 2016 | Mendlein John CEO Dir | Buy | Atyr Pharma Inc | LIFE | $3.52 | $8,800 | +0.99% |
Apr 05, 2016 | Apr 06, 2016 | Mendlein John CEO Dir | Buy | Atyr Pharma Inc | LIFE | $3.55 | $8,875 | +1.00% |
Oct 04, 2013 | Oct 07, 2013 | Mendlein John Dir | Buy | Fate Therapeutics Inc | FATE | $6 | $100,002 | +9.61% |